Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Eugia Pharma Specialities restarts production at terminally sterilized product lines
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The plant will drive pharmaceutical innovation in the Northeastern India
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
